1. Home
  2. CRMD vs NKX Comparison

CRMD vs NKX Comparison

Compare CRMD & NKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • NKX
  • Stock Information
  • Founded
  • CRMD 2006
  • NKX 2002
  • Country
  • CRMD United States
  • NKX United States
  • Employees
  • CRMD N/A
  • NKX N/A
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • NKX Finance/Investors Services
  • Sector
  • CRMD Health Care
  • NKX Finance
  • Exchange
  • CRMD Nasdaq
  • NKX Nasdaq
  • Market Cap
  • CRMD 738.4M
  • NKX 599.7M
  • IPO Year
  • CRMD 2010
  • NKX N/A
  • Fundamental
  • Price
  • CRMD $12.49
  • NKX $12.58
  • Analyst Decision
  • CRMD Strong Buy
  • NKX
  • Analyst Count
  • CRMD 6
  • NKX 0
  • Target Price
  • CRMD $15.67
  • NKX N/A
  • AVG Volume (30 Days)
  • CRMD 1.3M
  • NKX 109.3K
  • Earning Date
  • CRMD 03-11-2025
  • NKX 01-01-0001
  • Dividend Yield
  • CRMD N/A
  • NKX 4.37%
  • EPS Growth
  • CRMD N/A
  • NKX N/A
  • EPS
  • CRMD N/A
  • NKX N/A
  • Revenue
  • CRMD $12,262,234.00
  • NKX N/A
  • Revenue This Year
  • CRMD N/A
  • NKX N/A
  • Revenue Next Year
  • CRMD $246.41
  • NKX N/A
  • P/E Ratio
  • CRMD N/A
  • NKX N/A
  • Revenue Growth
  • CRMD 41184.20
  • NKX N/A
  • 52 Week Low
  • CRMD $2.89
  • NKX $9.78
  • 52 Week High
  • CRMD $13.85
  • NKX $12.00
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 70.88
  • NKX 45.07
  • Support Level
  • CRMD $7.91
  • NKX $12.42
  • Resistance Level
  • CRMD $13.09
  • NKX $12.92
  • Average True Range (ATR)
  • CRMD 0.70
  • NKX 0.23
  • MACD
  • CRMD 0.43
  • NKX 0.01
  • Stochastic Oscillator
  • CRMD 88.68
  • NKX 46.03

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.

About NKX Nuveen California AMT-Free Quality Municipal Income Fund

Nuveen California AMT-Free Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objectives are to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: